Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

New PNNL research makes it easier to differentiate between chemical and nuclear explosions.

Clarivate recently released the list of Highly Cited Researchers for 2022.

The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.

Researchers at PNNL leveraged their experiences to connect with attendees at the 2022 SACNAS National Diversity in STEM Conference, October 27–29, 2022, in San Juan, Puerto Rico.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

Silicone wristbands could be more convenient option for collecting exposure data.

PNNL researchers use machine learning and data analytics to assist with detection of nuclear proliferation and nuclear material trafficking.

PNNL experts in nuclear forensics helped lead laboratories around the world through a rigorous test involving nuclear materials.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

A new article reviews bio-orthogonal click chemistry reagents that can be used as probes to label metabolic pathways in plants and microbes.